Although the incidence of anemia in patients with inflammatory bowel disease (IBD), which comprises ulcerative colitis and Crohn’s disease, has reportedly decreased in the last few decades, it is still the most prevalent extraintestinal complication of IBD. Continue reading “Assessing the Impact of Anemia in Patients with IBD”
Congress Should Protect Patient Access to Much Needed Medications
If you’re a gastroenterologist in private practice, there is legislation being considered in the U.S. Senate that could force your patients to seek care in the more expensive hospital setting. Continue reading “Congress Should Protect Patient Access to Much Needed Medications”
Should Your Practice Open an In-Office Retail Pharmacy?
There are lots of good reasons to open an in-office retail pharmacy inside your gastroenterology clinic. It is becoming a very popular way to both increase patient medication compliance and to increase revenue for providers. While there are many benefits of having an in-office retail pharmacy, there are several factors to consider when deciding whether it’s the right move for your practice.
Continue reading “Should Your Practice Open an In-Office Retail Pharmacy?”
The Value of Biosimilars in the Treatment of IBD: Frequently Asked Questions
Biosimilars offer additional treatment options for patients with IBD. In this activity, faculty will review the role of biosimilars in the management of IBD and answer learner questions from the previous CME activity. Continue reading “The Value of Biosimilars in the Treatment of IBD: Frequently Asked Questions”
The Benefits of Joining a Group Purchasing Organization
Healthcare providers are constantly looking for ways to reduce spending and increase efficiency in their practices to better serve their patients. One way for a gastroenterology (GI) practice to do this is by joining a Group Purchasing Organization (GPO). Continue reading “The Benefits of Joining a Group Purchasing Organization”